Complications after radical prostatectomy or radiotherapy for prostate cancer: Results of a population-based, propensity score-matched analysis

Urology

Volumn 85, Issue 3, 2015, Pages 621-628

  Wallis, Christopher J D ^a   Herschorn, Sender ^a   Saskin, Refik ^a   Su, Jiandong ^a   Klotz, Laurence H ^a   Chang, Michelle ^a   Kulkarni, Girish S ^b   Lee, Yuna ^c   Kodama, Ronald T ^a   Narod, Steven A ^a   Nam, Robert K ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CANCER RADIOTHERAPY; CANCER SURGERY; COMORBIDITY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPENSITY SCORE; PROSTATE CANCER; PROSTATECTOMY; RADIATION INJURY;

EID: 84964247746     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.11.037     Document Type: Article

References (32)

1. R.K. Nam, P. Cheung, and S. Herschorn Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study Lancet Oncol 15 2014 223 231
2. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
3. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 719 748
4. D.B. Rubin Matching to remove bias in observational studies Biometrics 29 1973 159 183
5. P.C. Austin An introduction to propensity score methods for reducing the effects of confounding in observational studies Multivariate Behav Res 46 2011 399 424
6. E.P. Martens, W.R. Pestman, and A. de Boer Instrumental variables: application and limitations Epidemiology 17 2006 260 267
7. Center HSRD The Johns Hopkins ACG Case-mix System Reference Manual Version 7.0 2005 The Johns Hopkins University Bloomberg School of Public Health Baltimore, MD
8. A. Berrington de Gonzalez, R.E. Curtis, and S.F. Kry Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries Lancet Oncol 12 2011 353 360
9. R.B. D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
10. Care OMoHaL-t. Schedule of Benefits for Physician Services Under the Health Insurance Act. 2014, May 23, 2014.
11. A. Bece, and G. Hruby Complications of prostate cancer treatment Lancet Oncol 15 2014 e149 e150
12. R.C. Chen, D.A. Hamstra, H.M. Sandler, and A.L. Zietman Complications of prostate cancer treatment Lancet Oncol 15 2014 e150
13. R. Halperin, B. Maas, and T. Pickles Complications of prostate cancer treatment Lancet Oncol 15 2014 e151 152
14. K.D. Linton, H.H. Woo Twitter International Urology Journal Club Complications of prostate cancer treatment Lancet Oncol 15 2014 e150 e151
15. P.C. Albertsen, J.A. Hanley, and D.F. Penson 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort J Urol 177 2007 932 936
16. Y.N. Wong, N. Mitra, and G. Hudes Survival associated with treatment vs observation of localized prostate cancer in elderly men JAMA 296 2006 2683 2693
17. Y.H. Shao, S. Kim, and D.F. Moore Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: results of a population-based, propensity score-matched analysis Eur Urol 65 2014 693 700
18. A.L. Potosky, W.W. Davis, and R.M. Hoffman Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study J Natl Cancer Inst 96 2004 1358 1367
19. M.J. Resnick, T. Koyama, and K.H. Fan Long-term functional outcomes after treatment for localized prostate cancer N Engl J Med 368 2013 436 445
20. P.C. Austin A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003 Stat Med 27 2008 2037 2049
21. J.M. Brooks, and R.L. Ohsfeldt Squeezing the balloon: propensity scores and unmeasured covariate balance Health Serv Res 48 2013 1487 1507
22. J. Hadley, K.R. Yabroff, and M.J. Barrett Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data J Natl Cancer Inst 102 2010 1780 1793
23. E.L. Korn, and B. Freidlin Methodology for comparative effectiveness research: potential and limitations J Clin Oncol 30 2012 4185 4187
24. A. Bill-Axelson, L. Holmberg, and F. Filen Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial J Natl Cancer Inst 100 2008 1144 1154
25. A. Bill-Axelson, L. Holmberg, and M. Ruutu Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 352 2005 1977 1984
26. A.J. Vickers Re: Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data J Natl Cancer Inst 103 2011 1134 author reply 1134-1135
27. E.B. Lamont, D. Hayreh, and K.E. Pickett Is patient travel distance associated with survival on phase II clinical trials in oncology? J Natl Cancer Inst 95 2003 1370 1375
28. Y.F. Kuo, J.E. Montie, and V.B. Shahinian Reducing bias in the assessment of treatment effectiveness: androgen deprivation therapy for prostate cancer Med Care 50 2012 374 380
29. C.N. Klabunde, J.L. Warren, and J.M. Legler Assessing comorbidity using claims data: an overview Med Care 40 8 suppl 2002 IV-26 IV-35
30. A.S. Gershon, L. Wang, and T. To Survival with tiotropium compared to long-acting Beta-2-agonists in chronic obstructive pulmonary disease COPD 5 2008 229 234
31. D.J. Brenner, R.E. Curtis, E.J. Hall, and E. Ron Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery Cancer 88 2000 398 406
32. T.E. Rohan, T.G. Hislop, and G.R. Howe Cigarette smoking and risk of prostate cancer: a population-based case-control study in Ontario and British Columbia, Canada Eur J Cancer Prev 6 1997 382 388